BiotechTube
Home/Braveheart Bio/Michele Anderson
MA

Michele Anderson

Chief Development Officer

Braveheart Bio

Therapeutic Areas

CardiovascularMetabolic

Braveheart Bio Pipeline

DrugIndicationPhase
BHB-1893Hypertrophic Cardiomyopathy (Obstructive and Non-obstructive)Phase 3

Leadership Team at Braveheart Bio

TM
Travis Murdoch, M.D.
Chief Executive Officer
ED
Emil deGoma, M.D.
Chief Medical Officer
ME
Marc Evanchik, M.S.
Chief Scientific Officer
PR
Paul Rickey
Chief Financial Officer
View full Braveheart Bio profile